» Articles » PMID: 20182030

Caffeine, Adenosine Receptors, and Synaptic Plasticity

Overview
Publisher Sage Publications
Specialties Geriatrics
Neurology
Date 2010 Feb 26
PMID 20182030
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Few studies to date have looked at the effects of caffeine on synaptic plasticity, and those that did used very high concentrations of caffeine, whereas the brain concentrations attained by regular coffee consumption in humans should be in the low micromolar range, where caffeine exerts pharmacological actions mainly by antagonizing adenosine receptors. Accordingly, rats drinking caffeine (1 g/L) for 3 weeks, displayed a concentration of caffeine of circa 22 microM in the hippocampus. It is known that selective adenosine A1 receptor antagonists facilitate, whereas selective adenosine A2A receptor antagonists attenuate, long term potentiation (LTP) in the hippocampus. Although caffeine is a non-selective antagonist of adenosine receptors, it attenuates frequency-induced LTP in hippocampal slices in a manner similar to selective adenosine A2A receptor antagonists. These effects of low micromolar concentration of caffeine (30 microM) are maintained in aged animals, which is important when a possible beneficial effect for caffeine in age-related cognitive decline is proposed. Future studies will still be required to confirm and detail the involvement of A1 and A2A receptors in the effects of caffeine on hippocampal synaptic plasticity, using both pharmacological and genetic approaches.

Citing Articles

Utilizing kombucha culture for coffee fermentation and biochemical characteristic analysis.

Kim H, Jeon J, Lee J, Song C, Gu B, Kim N Curr Res Food Sci. 2025; 10:100996.

PMID: 40018374 PMC: 11867273. DOI: 10.1016/j.crfs.2025.100996.


Association of caffeine consumption with cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease: A BALTAZAR cohort study.

Blum D, Cailliau E, Behal H, Vidal J, Delaby C, Buee L Alzheimers Dement. 2024; 20(10):6948-6959.

PMID: 39099181 PMC: 11485411. DOI: 10.1002/alz.14169.


Microglial purinergic signaling in Alzheimer's disease.

Mei S, Zhang N, Wang M, Lv P, Liu Q Purinergic Signal. 2024; .

PMID: 38910192 DOI: 10.1007/s11302-024-10029-8.


Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer's Disease.

Reza-Zaldivar E, Jacobo-Velazquez D ACS Omega. 2023; 8(39):35499-35522.

PMID: 37810693 PMC: 10552500. DOI: 10.1021/acsomega.3c04855.


On the participation of adenosinergic receptors in the reconsolidation of spatial long-term memory in male rats.

Fiebrantz A, Felski Leite L, Dal Pisol Schwab E, Bonini J, da Silva W Learn Mem. 2023; 30(10):260-270.

PMID: 37802547 PMC: 10561635. DOI: 10.1101/lm.053785.123.